BioHealth News Archive

Massachusetts-Based Cell Therapy Company Coming to Rockville  | Montgomery Community Media

Massachusetts-Based Cell Therapy Company Coming to Rockville  | Montgomery Community Media

TCR² Therapeutics Inc., based in Cambridge, is a clinical-stage company that develops T-cell therapies for patients with cancer. In a statement, TCR² said it…

Read More
BioHealth Innovation Recruiting Managing Director, Economic Development Position

BioHealth Innovation Recruiting Managing Director, Economic Development Position

Montgomery County, Maryland County Executive Marc Elrich has notified the Montgomery County Council of his appointment of BHI's Managing Director for Economic Development, Judy…

Read More
Fireside Chat – Development of Countermeasures for Viral Diseases – Webinar Registration – Zoom

Fireside Chat – Development of Countermeasures for Viral Diseases – Webinar Registration – Zoom

Development of Countermeasures for Viral Diseases The best defense against viral infectious diseases are safe and effective medical countermeasures that function at level of…

Read More
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility — TCR2 Therapeutics

TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility — TCR2 Therapeutics

CAMBRIDGE, Mass., March 29, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell…

Read More
BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic | Global Biodefense

BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic | Global Biodefense

BioFactura, Inc. today announced a contract option activation of over $13 million by the Biomedical Advanced Research and Development Authority (BARDA), part of the…

Read More
8 digital health trends emerging from the pandemic – Technical.ly Baltimore

8 digital health trends emerging from the pandemic – Technical.ly Baltimore

What did we learn during the pandemic, and what should we watch moving forward? Those are two of the key questions that many professional…

Read More
209 PERRY PARKWAY – GAITHERSBURG, MARYLAND, 20877

209 PERRY PARKWAY – GAITHERSBURG, MARYLAND, 20877

SPACE FEATURES Existing laboratory suite with closed and open o ices Grade-level loading doors 17' ceiling heights • breakroom with kitchenette 180 free surface…

Read More
What It Takes to Manufacture a Vaccine | NAM

What It Takes to Manufacture a Vaccine | NAM

You may not know it, but one company has the capacity to manufacture bulk drug substance for more than a billion doses of COVID-19…

Read More
Leveraging Artificial Intelligence in Human Health | B.S. in Biocomputational Engineering

Leveraging Artificial Intelligence in Human Health | B.S. in Biocomputational Engineering

The University of Maryland hosted a free webinar, Leveraging Artificial Intelligence in Human Health, on Friday, March 19, 2020. This event featured a fireside chat with Dr. Robert…

Read More
Northern Virginia’s bioscience industry grows stronger | WTOP

Northern Virginia’s bioscience industry grows stronger | WTOP

Exciting things are happening at Innovation Park in Manassas. Researchers are working on global solutions, industry jobs are on the rise, and new facilities…

Read More
Knowing Your Assets with Richard Bendis Talent Talks Ep. 14

Knowing Your Assets with Richard Bendis Talent Talks Ep. 14

Check out this weeks episode of Talent Talks on YouTube and Spotify! This week we sit with Richard Bendis President and CEO of BioHealth…

Read More
5 Questions with Natalie McKinney, Industry Programs Director, Biologics, US Pharmacopeia · BioBuzz

5 Questions with Natalie McKinney, Industry Programs Director, Biologics, US Pharmacopeia · BioBuzz

“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share a little…

Read More
Construction on New Buildings Underway at Port Covington Development

Construction on New Buildings Underway at Port Covington Development

New buildings are now rising out of the ground on the first major phase of construction at the 235-acre, $5.5-billion, multi-decade Port Covington development.…

Read More
CASI Pharmaceuticals Announces Pricing Of $32,500,000 Public Offering Of Common Stock

CASI Pharmaceuticals Announces Pricing Of $32,500,000 Public Offering Of Common Stock

ROCKVILLE, Md. and BEIJING, March 24, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative…

Read More
NeoImmuneTech Announces Closing of Initial Public Offering – BioHealth Capital Region

NeoImmuneTech Announces Closing of Initial Public Offering – BioHealth Capital Region

ROCKVILLE, Md.–(BUSINESS WIRE)–NeoImmuneTech, Inc. (KOSDAQ: 950220), a clinical-stage T cell-focused biopharmaceutical company, today announced the closing of its initial public offering of 3,133,334 shares…

Read More